ArticleACS pharmacology & translational science2020

Modeling Adaptive Resistance of KRAS Mutant Colorectal Cancer to MAPK Pathway Inhibitors with a Three-Dimensional Tumor Model.

Pradip Shahi Thakuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.